HCP, Inc.  

(Public, NYSE:HCP)   Watch this stock  
Find more results for HCP
30.25
+0.12 (0.38%)
Real-time:   1:56PM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 29.70 - 30.29
52 week 25.11 - 40.43
Open 29.87
Vol / Avg. 2.19M/4.67M
Mkt cap 14.49B
P/E     -
Div/yield 0.37/4.89
EPS -0.07
Shares 467.97M
Beta 0.22
Inst. own 95%
Feb 7, 2017
Q4 2016 HCP Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 1, 2016
Q3 2016 HCP Inc Earnings Call - Webcast
Nov 1, 2016
Q3 2016 HCP Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 23.86% -21.92%
Operating margin 41.31% -4.25%
EBITD margin - 72.08%
Return on average assets 2.96% -2.61%
Return on average equity 6.56% -5.58%
Employees 187 -
CDP Score - 98 A minus

Address

1920 Main St Ste 1200
IRVINE, CA 92614-7230
United States - Map
+1-949-4070700 (Phone)
+1-562-7335200 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

HCP, Inc. (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital. Its portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. It has interests in unconsolidated joint ventures representing approximately 30 properties primarily in its senior housing, life science and medical office segments. The Company has interests in approximately 530 senior housing facilities, including over 25 properties owned by its unconsolidated joint ventures. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes and continuing care retirement communities. It has interests in approximately 310 post-acute/skilled nursing facilities.

Officers and directors

Michael Dale McKee Executive Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Thomas M. Herzog Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Scott A. Anderson Executive Vice President, Chief Accounting Officer
Age: 54
Bio & Compensation  - Reuters
J. Justin Hutchens President
Age: 41
Bio & Compensation  - Reuters
Troy E. McHenry Executive Vice President, General Counsel, Corporate Secretary
Age: 43
Bio & Compensation  - Reuters
Jonathan M. Bergschneider Executive Vice President - Life Science Estates
Age: 41
Bio & Compensation  - Reuters
Thomas D. Kirby Executive Vice President - Acquisitions and Valuations
Age: 69
Bio & Compensation  - Reuters
Thomas M. Klaritch CPA Executive Vice President - Medical Office Properties
Age: 58
Bio & Compensation  - Reuters
Darren A. Kowalske Executive Vice President - Asset Management, Senior Housing and Care
Age: 55
Bio & Compensation  - Reuters
John Lu Executive Vice President - Corporate Finance and Investments
Age: 37
Bio & Compensation  - Reuters